D. A. Upeka Chathurangani
D. A. Upeka Chathurangani has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Medha Jaimini Gunaratna
Department of Chemistry, Faculty of Science, University of Kelaniya, Kelaniya 11600, Sri Lanka
2 shared publications - D. M. Saruwage1 shared publication
- D. M. W. S. Dissanayake
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication - Dinusha N. Udukala
Department of Chemistry, Kansas State University, Manhattan, KS 66506, USA
1 shared publication - Dinusha Nishani Udukala
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication - G. Mashooda Jayah
College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka
1 shared publication
Latest Publications
- Open Access
- 16 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1013
Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives
Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro. Methods: The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS. Results: In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.
- 16 August 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (8) , 1013
Open AccessSynthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives
Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro. Methods: The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS. Results: In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.
- Open Access
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Optimizing the size of Bi2S3 Quantum dots for efficient Quantum dot/Natural dye co-sensitized solar cells
Low-cost co-sensitized solar cells were fabricated using natural dye and Bismuth trisulfide (Bi₂S₃) quantum dots. The pigment extracted from the bark of Dialium ovoideum, used as the natural dye sensitizer. Bi2S3 quantum dots were chosen as co-sensitizers because of their non-toxic nature and suitable band gap for light harvesting. The configuration of the fabricated DSSC is FTO/TiO2/Dye/(I-/I-3)/Pt and iodide/triiodide (I-/I-3) redox couple used as the electrolyte. The DSSCs achieved an efficiency of 0.593 %, an open-circuit voltage (Voc) of 414.7 mV, and a short-circuit current density (Jsc) of 0.242 mA cm-2under 100 mW cm-2 illumination with an AM 1.5 spectral filter for a 0.25 cm2 active area. Configuration of the co-sensitized cell is FTO/TiO2/QD/Dye/(I-/I-3)/Pt. This resulted in an efficiency of 0.726% and a short-circuit current density of 1.378 mA cm-2. Overall, this study contributes to the development of cost-effective and environmentally friendly photovoltaic cells.
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessOptimizing the size of Bi2S3 Quantum dots for efficient Quantum dot/Natural dye co-sensitized solar cells
Low-cost co-sensitized solar cells were fabricated using natural dye and Bismuth trisulfide (Bi₂S₃) quantum dots. The pigment extracted from the bark of Dialium ovoideum, used as the natural dye sensitizer. Bi2S3 quantum dots were chosen as co-sensitizers because of their non-toxic nature and suitable band gap for light harvesting. The configuration of the fabricated DSSC is FTO/TiO2/Dye/(I-/I-3)/Pt and iodide/triiodide (I-/I-3) redox couple used as the electrolyte. The DSSCs achieved an efficiency of 0.593 %, an open-circuit voltage (Voc) of 414.7 mV, and a short-circuit current density (Jsc) of 0.242 mA cm-2under 100 mW cm-2 illumination with an AM 1.5 spectral filter for a 0.25 cm2 active area. Configuration of the co-sensitized cell is FTO/TiO2/QD/Dye/(I-/I-3)/Pt. This resulted in an efficiency of 0.726% and a short-circuit current density of 1.378 mA cm-2. Overall, this study contributes to the development of cost-effective and environmentally friendly photovoltaic cells.